P3 Health Partners (PIII) Stock Jumps 488% in 30 Days — 2026 Revenue Boom and Debt Cut Fuel Rally

Quick overview

P3 Health Partners company stock has been showing an increase for the past several days. You will be surprised to know that this stock has shown a 488.21 percent increase in the past one month and in the last five days, it has again shown a 56.41 percent increase. At the time we are writing this article, this stock is trading at $16.47 and is showing a 3.39 percent increase for today.

What This Company Really Does

Before explaining the reason behind the excellent performance of this stock, let me give you a brief introduction to this company. P3 Health Partners is basically a company that works with doctors to provide better care to their patients. Their main focus is on elderly people who use Medicare Advantage insurance. Their job is to keep their patients healthy, reduce unnecessary hospital visits, save money for insurance companies, and satisfy their patients.

Why This Stock Is Rising

Now let’s talk about the reason behind the excellent performance of this company’s stock, in which first comes their strong Quarter 1 2026 report. The company reported revenue of $386 million and also made a good profit this quarter, which is a big improvement compared to last year when they had heavy losses.

Not only this, but the company has also largely resolved its old debt issue. In a recent deal, instead of repaying their debt in cash, they gave shares of their own company to the people they owed money to. They also raised an additional $30 million from new investors. Because of this deal, the company is now under much less debt and their financial situation has become much better and safer.

You should also know that this company has intentionally reduced its at-risk members so that it can further improve the quality of its services. Now this company has 1,060,000 members who are at risk. This is actually seen as a positive sign, because it shows the company is focusing more on higher-quality members rather than just higher numbers.

Company Expecting More Growth Soon

Considering all these positive developments, P3 Health Partners has increased its full-year 2026 guidance. They are expecting to generate revenue between $1.5 billion and $1.65 billion and their profit is expected to be between $20 million and $60 million.

Analysts have also liked the stock. TD Cowen and Lake Street have both increased their price target to $14 and they believe that the company is performing very well in patient care, their deals with insurance companies are going very well, and they are managing their debts and costs very efficiently. That is why many analysts have given it a Buy rating.

ABOUT THE AUTHOR See More

Arslan Butt

Lead Markets Analyst – Multi-Asset (FX, Commodities, Crypto)

Arslan Butt serves as the Lead Commodities and Indices Analyst, bringing a wealth of expertise to the field. With an MBA in Behavioral Finance and active progress towards a Ph.D., Arslan possesses a deep understanding of market dynamics. His professional journey includes a significant role as a senior analyst at a leading brokerage firm, complementing his extensive experience as a market analyst and day trader. Adept in educating others, Arslan has a commendable track record as an instructor and public speaker. His incisive analyses, particularly within the realms of cryptocurrency and forex markets, are showcased across esteemed financial publications such as ForexCrunch, InsideBitcoins, and EconomyWatch, solidifying his reputation in the financial community.